Comparison of Ocrelizumab and Rituximab over Two Years of Treatment for Multiple Sclerosis

被引：0
|
作者：
Vollmer, B. [1 ]
Nair, K. [2 ]
Sillau, S. [3 ]
Corboy, J. R. [3 ]
Alvarez, E. [3 ]
机构：
[1] Univ Colorado, Neurol, Denver, CO USA
[2] Univ Colorado, Pharm, Aurora, CO USA
[3] Univ Colorado, Neurol, Aurora, CO USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P159
引用
收藏
页码：92 / 93
页数：2
相关论文
共 50 条
  • [21] Comparison of rituximab vs fingolimod, dimethyl fumarate and natalizumab in the treatment of multiple sclerosis: two year experience
    Vollmer, B.
    Nair, K.
    Sillau, S.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 267 - 268
  • [22] Rituximab for the treatment of multiple sclerosis: a review
    Chisari, Clara Grazia
    Sgarlata, Eleonora
    Arena, Sebastiano
    Toscano, Simona
    Luca, Maria
    Patti, Francesco
    JOURNAL OF NEUROLOGY, 2022, 269 (01) : 159 - 183
  • [23] Studies on rituximab in the treatment of multiple sclerosis
    Waubant, E.
    MULTIPLE SCLEROSIS, 2007, 13 (09): : 1212 - 1213
  • [24] Rituximab for the treatment of multiple sclerosis: a review
    Clara Grazia Chisari
    Eleonora Sgarlata
    Sebastiano Arena
    Simona Toscano
    Maria Luca
    Francesco Patti
    Journal of Neurology, 2022, 269 : 159 - 183
  • [25] Comparison of Tolerability Between Rituximab and Ocrelizumab
    Moss, Brandon
    Love, Thomas
    Baldassari, Laura
    Planchon, Sarah
    Cohen, Jeffrey
    Ontaneda, Daniel
    NEUROLOGY, 2020, 94 (15)
  • [26] Smoking Status over Two Years in Patients with Multiple Sclerosis
    Marrie, Ruth Ann
    Cutter, Gary
    Tyry, Tuula
    Campagnolo, Denise
    Vollmer, Timothy
    NEUROEPIDEMIOLOGY, 2009, 32 (01) : 72 - 79
  • [27] Real-world experience with Ocrelizumab in Multiple Sclerosis patients: Two years follow up in Qatar
    Yousuf, Wajiha
    Ganesan, Gowrii Saswathy
    Humos, Basel
    Baig, Tehniyat
    Canibano, Beatriz
    Deleu, Dirk
    NEUROLOGY, 2021, 96 (15)
  • [28] Ocrelizumab: A Review in Multiple Sclerosis
    Syed, Yahiya Y.
    CNS DRUGS, 2018, 32 (09) : 883 - 890
  • [29] Ocrelizumab in pediatric multiple sclerosis
    Amirov, Ceren Bibinoglu
    Saltik, Sema
    Yalcinkaya, Cengiz
    Tutuncu, Melih
    Saip, Sabahattin
    Siva, Aksel
    Uygunoglu, Ugur
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 43 : 1 - 5
  • [30] Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
    Carmen Alcalá
    Carlos Quintanilla-Bordás
    Francisco Gascón
    Ángel Perez Sempere
    Laura Navarro
    María Carcelén-Gadea
    Lamberto Landete
    Javier Mallada
    Emmanuel Cañizares
    Antonio Belenguer
    Sara Carratalá
    José Andrés Domínguez
    Francisco Carlos Pérez-Miralles
    Sara Gil-Perotín
    Raquel Gasqué
    Laura Cubas
    Jéssica Castillo
    Bonaventura Casanova
    Journal of Neurology, 2022, 269 : 3676 - 3681
12345